FR07C0037I1 - - Google Patents

Info

Publication number
FR07C0037I1
FR07C0037I1 FR07C0037C FR07C0037I1 FR 07C0037 I1 FR07C0037 I1 FR 07C0037I1 FR 07C0037 C FR07C0037 C FR 07C0037C FR 07C0037 I1 FR07C0037 I1 FR 07C0037I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR07C0037(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR07C0037I1 publication Critical patent/FR07C0037I1/fr
Application granted granted Critical
Publication of FR07C0037I2 publication Critical patent/FR07C0037I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
FR07C0037C 1997-06-10 2007-07-06 Active FR07C0037I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10
PCT/EP1998/003427 WO1998056772A1 (fr) 1997-06-10 1998-06-08 Modification cristalline de 1-(2,6-difluorobenzyle)-1h-1,2,3-triazole-4-carboxamide et son utilisation en tant qu'anti-epileptique

Publications (2)

Publication Number Publication Date
FR07C0037I1 true FR07C0037I1 (fr) 2007-08-17
FR07C0037I2 FR07C0037I2 (fr) 2008-05-16

Family

ID=4209650

Family Applications (1)

Application Number Title Priority Date Filing Date
FR07C0037C Active FR07C0037I2 (fr) 1997-06-10 2007-07-06

Country Status (37)

Country Link
US (6) US6740669B1 (fr)
EP (2) EP0994864B1 (fr)
JP (2) JP3672575B2 (fr)
KR (2) KR100409168B1 (fr)
CN (3) CN1159300C (fr)
AR (4) AR012946A1 (fr)
AT (2) ATE232852T1 (fr)
AU (2) AU725517B2 (fr)
BR (2) BR9804947A (fr)
CA (3) CA2614926C (fr)
CO (2) CO4940448A1 (fr)
CY (1) CY2007014I1 (fr)
CZ (2) CZ292481B6 (fr)
DE (3) DE69811500T2 (fr)
DK (2) DK0994864T3 (fr)
ES (2) ES2197485T3 (fr)
FR (1) FR07C0037I2 (fr)
HK (3) HK1028241A1 (fr)
HU (2) HU225153B1 (fr)
ID (2) ID21014A (fr)
IL (2) IL125732A (fr)
LU (1) LU91345I2 (fr)
MY (2) MY120156A (fr)
NL (1) NL300284I2 (fr)
NO (2) NO329314B1 (fr)
NZ (2) NZ331371A (fr)
PE (2) PE79799A1 (fr)
PL (2) PL192114B1 (fr)
PT (1) PT994864E (fr)
RU (2) RU2194041C2 (fr)
SI (2) SI0994863T1 (fr)
SK (2) SK283734B6 (fr)
TR (2) TR199801630T1 (fr)
TW (2) TW403740B (fr)
UY (1) UY25844A1 (fr)
WO (2) WO1998056772A1 (fr)
ZA (2) ZA984966B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CA2486174A1 (fr) * 2002-05-31 2003-12-11 Schering Corporation Polymorphes d'un inhibiteur v de xanthine phosphodiesterase
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (fr) * 2008-10-13 2010-04-22 Cipla Limited Procede pour la preparation de rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
RU2594155C2 (ru) * 2009-09-04 2016-08-10 Тэктикал Терапеутикс, Инк Новые композиции и способы получения 5-амино- или замещенных амино-1,2,3-триазолов и триазол-оротатных композиций
EP2563766B1 (fr) * 2010-04-30 2014-06-25 Laboratorios Lesvi, S.L. Procédé amélioré pour la préparation d'un intermédiaire du rufinamide
EP2465853A1 (fr) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorphe de rufinamide et son procédé d'obtention
ITMI20110718A1 (it) * 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (fr) 2019-11-20 2021-05-27 Medichem, S.A. Composition solide contenant du rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
FI93544C (fi) * 1985-04-18 1995-04-25 Ciba Geigy Ag Menetelmä fluorattujen, antikonvulsiivisesti vaikuttavien 1-bentsyyli-1H-1,2,3-triatsoliyhdisteiden valmistamiseksi
CA2002864C (fr) 1988-11-29 1999-11-16 Eddy J. E. Freyne Derives de quinoline, quinazoline ou quinoxaline (1h-azol-1-ylmethyl) substitues
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
WO1991001724A1 (fr) 1989-07-27 1991-02-21 G.D. Searle & Co. Promedicaments a selectivite renale pour le traitement de l'hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
EP0556393B1 (fr) 1990-11-06 2000-07-26 Yamanouchi Pharmaceutical Co. Ltd. Derive de pyrazine fusionnee
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
KR100419355B1 (ko) 1995-02-22 2004-06-04 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 무정형피레타나이드,피레타나이드다형체,이들의제조방법및이를포함하는약제학적조성물
SK283990B6 (sk) * 1996-07-11 2004-07-07 Novartis Ag Spôsob prípravy 1-substituovaných 4-kyano-1,2,3-triazolov, 4-kyano-1-(2,6-difluórbenzyl)-1H-1,2,3-triazol
TW403740B (en) * 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
HUP0000798A2 (hu) 2000-10-30
CY2007014I2 (el) 2009-11-04
CZ292260B6 (cs) 2003-08-13
EP0994864A1 (fr) 2000-04-26
PE80999A1 (es) 1999-09-06
AR012945A1 (es) 2000-11-22
SK109498A3 (en) 1998-12-02
NO329315B1 (no) 2010-09-27
BR9804947A (pt) 1999-08-24
AU725517B2 (en) 2000-10-12
DE69811500D1 (de) 2003-03-27
JP3672575B2 (ja) 2005-07-20
HUP0002113A2 (hu) 2001-02-28
TW403740B (en) 2000-09-01
NO983666D0 (no) 1998-08-11
PE79799A1 (es) 1999-09-03
CZ253398A3 (cs) 1999-04-14
SK109398A3 (en) 1998-12-02
NO329314B1 (no) 2010-09-27
CA2256013C (fr) 2007-10-16
CO4940452A1 (es) 2000-07-24
CN1298708C (zh) 2007-02-07
PT994864E (pt) 2003-07-31
HU225153B1 (en) 2006-07-28
US7750028B2 (en) 2010-07-06
CA2256015A1 (fr) 1998-12-17
DE69811500T2 (de) 2004-04-01
HK1028241A1 (en) 2001-02-09
CA2256013A1 (fr) 1998-12-17
DK0994864T3 (da) 2003-07-21
US20100310655A1 (en) 2010-12-09
PL192114B1 (pl) 2006-08-31
NL300284I2 (nl) 2007-11-01
ATE232852T1 (de) 2003-03-15
CN1132820C (zh) 2003-12-31
US20040167186A1 (en) 2004-08-26
CY2007014I1 (el) 2009-11-04
AR061004A2 (es) 2008-07-30
HK1028031A1 (en) 2001-02-02
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
ATE237599T1 (de) 2003-05-15
CA2614926C (fr) 2010-02-09
KR19990087836A (ko) 1999-12-27
SK283685B6 (sk) 2003-12-02
SI0994864T1 (en) 2003-10-31
NO983666L (no) 1998-12-17
EP0994863A1 (fr) 2000-04-26
US8076362B2 (en) 2011-12-13
IL125733A (en) 2002-12-01
JP3672574B2 (ja) 2005-07-20
NZ331370A (en) 2000-08-25
ZA984966B (en) 1999-01-11
DE69813560D1 (de) 2003-05-22
RU2198167C2 (ru) 2003-02-10
CO4940448A1 (es) 2000-07-24
AU8437298A (en) 1998-12-30
DE69813560T2 (de) 2004-02-05
PL330798A1 (en) 1999-06-07
NZ331371A (en) 2000-08-25
MY120156A (en) 2005-09-30
RU2194041C2 (ru) 2002-12-10
EP0994864B1 (fr) 2003-04-16
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (fr) 1998-12-17
US6455556B2 (en) 2002-09-24
DE122007000051I1 (de) 2007-11-08
ID21014A (id) 1999-04-08
HUP0002113A3 (en) 2002-09-30
US20030125568A1 (en) 2003-07-03
US20010037029A1 (en) 2001-11-01
UY25844A1 (es) 2001-08-27
NO983667L (no) 1998-12-17
KR100425656B1 (ko) 2004-05-17
WO1998056772A1 (fr) 1998-12-17
KR100409168B1 (ko) 2004-01-31
IL125733A0 (en) 1999-04-11
CA2614926A1 (fr) 1998-12-17
PL330764A1 (en) 1999-05-24
KR19990087835A (ko) 1999-12-27
CA2256015C (fr) 2008-06-03
AU725528B2 (en) 2000-10-12
ES2197485T3 (es) 2004-01-01
SI0994863T1 (en) 2003-08-31
BR9804946A (pt) 1999-08-24
TW526195B (en) 2003-04-01
JP2000516259A (ja) 2000-12-05
DK0994863T3 (da) 2003-05-26
HUP0000798A3 (en) 2000-10-30
CZ292481B6 (cs) 2003-09-17
MY125854A (en) 2006-08-30
ZA984967B (en) 1999-01-11
US20060116520A1 (en) 2006-06-01
CN1259127A (zh) 2000-07-05
IL125732A (en) 2002-12-01
EP0994863B1 (fr) 2003-02-19
PL191943B1 (pl) 2006-07-31
IL125732A0 (en) 1999-04-11
LU91345I9 (fr) 2018-12-31
CZ253498A3 (cs) 1999-04-14
DE122007000051I2 (de) 2009-02-19
US6740669B1 (en) 2004-05-25
ID27660A (id) 2001-04-19
AR012946A1 (es) 2000-11-22
HK1028242A1 (en) 2001-02-09
CN1159300C (zh) 2004-07-28
AU8437198A (en) 1998-12-30
CN1217716A (zh) 1999-05-26
LU91345I2 (fr) 2007-09-04
AR061005A2 (es) 2008-07-30
HU226107B1 (en) 2008-04-28
CN1572789A (zh) 2005-02-02
ES2192779T3 (es) 2003-10-16
FR07C0037I2 (fr) 2008-05-16
TR199801630T1 (xx) 1999-06-21
JP2000516258A (ja) 2000-12-05
TR199801631T1 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
IN190318B (fr)
CH0944937H2 (fr)
ITBZ970019A0 (fr)
IN189554B (fr)
IN191040B (fr)
IN190330B (fr)
ITMI970310V0 (fr)
IN185745B (fr)
IN183758B (fr)
IN182944B (fr)
ITMI971065A0 (fr)
ITTO970486A0 (fr)
ITMI971474A0 (fr)
CN3058088S (fr)
CN3057613S (fr)
CN3059079S (fr)
CN3059024S (fr)
CN3058984S (fr)
CN3058923S (fr)
CN3058533S (fr)
CN3058531S (fr)
CN3058462S (fr)
CN3058320S (fr)
CN3058162S (fr)
CN3059549S (fr)